找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Identification of Biomarkers, New Treatments, and Vaccines for COVID-19; Paul C. Guest Book 2021 The Editor(s) (if applicable) and The Aut

[復(fù)制鏈接]
樓主: Nixon
11#
發(fā)表于 2025-3-23 12:24:09 | 只看該作者
Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reason explanations for this disparity are not clear. Thus, we attempted to identify rational explanations about age-related differences as reported in different studies. Given the incomplete data on SARS-CoV-2, some information has been gathered from other studies of earlier coronavirus or influenza outb
12#
發(fā)表于 2025-3-23 14:35:31 | 只看該作者
13#
發(fā)表于 2025-3-23 20:58:38 | 只看該作者
14#
發(fā)表于 2025-3-23 22:44:19 | 只看該作者
15#
發(fā)表于 2025-3-24 05:10:07 | 只看該作者
16#
發(fā)表于 2025-3-24 08:14:43 | 只看該作者
How Do We Manage Breastfeeding During the COVID-19 Pandemic? including sexual and reproductive health, publishing in all of these areas has increased lately. One aspect that requires basing on scientific evidence is breastfeeding. There are some controversies in the literature on the breastfeeding management in confirmed COVID-19 mothers. Breast milk is exce
17#
發(fā)表于 2025-3-24 12:21:45 | 只看該作者
18#
發(fā)表于 2025-3-24 16:42:15 | 只看該作者
Using Ozone Therapy as an Option for Treatment of COVID-19 Patients: A Scoping Review study the effect of ozone therapy on COVID-19 patients and the available supporting evidence. Electronic databases including MEDLINE (via PubMed), EMBASE, Cochrane Library (CENTRAL), and TRIP, clinical trial registries, and preprint sources were searched for published evidence-based articles. In ad
19#
發(fā)表于 2025-3-24 22:10:53 | 只看該作者
20#
發(fā)表于 2025-3-25 02:44:43 | 只看該作者
Topical Oral and Intranasal Antiviral Agents for Coronavirus Disease 2019 (COVID-19)n the oral and nasal cavities, agents that act on these two areas have the potential for large therapeutic and prophylactic benefit. A literature review was conducted to elucidate the possible agents useful in treatment of SARS-CoV-2. These agents were evaluated for their current applications, adver
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-27 06:06
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平乐县| 克拉玛依市| 当涂县| 卓资县| 长汀县| 南召县| 自贡市| 长治县| 双鸭山市| 玉山县| 南丹县| 克山县| 启东市| 府谷县| 繁昌县| 五指山市| 成武县| 新兴县| 武威市| 纳雍县| 那曲县| 海安县| 黄石市| 婺源县| 马鞍山市| 广南县| 华容县| 乌鲁木齐市| 广德县| 洛浦县| 正阳县| 安泽县| 罗江县| 安仁县| 大足县| 岗巴县| 阿图什市| 台湾省| 密云县| 麻城市| 云霄县|